None listed
Conditions
Interventions
investigational material(s)
Generic name etc : -
INN of investigational material : insulin degludec and insulin aspart
Therapeutic category code : 249 Other hormone preparations (including antihormon
Sponsors
Novo Nordisk Pharma Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: -
Exclusion criteria
Exclusion criteria: -
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| efficacy - | — |
Secondary
| Measure | Time frame |
|---|---|
| safety efficacy - | — |
Countries
Japan
Outcome results
None listed